Peel Hunt Reaffirms “Buy” Rating for Genus (LON:GNS)
Genus (LON:GNS)‘s stock had its “buy” rating reaffirmed by stock analysts at Peel Hunt in a research report issued on Thursday, LSE.Co.UK reports. They currently have a GBX 3,200 ($41.81) price objective on the stock. Peel Hunt’s target price points to a potential upside of 23.74% from the company’s previous close.
GNS has been the topic of a number of other reports. Stifel Nicolaus started coverage on shares of Genus in a research note on Wednesday, May 29th. They issued a “hold” rating and a GBX 2,685 ($35.08) target price on the stock. Peel Hunt reissued a “buy” rating and issued a GBX 3,200 ($41.81) target price on shares of Genus in a research note on Thursday. Finally, Liberum Capital reissued a “buy” rating on shares of Genus in a research note on Friday, May 17th. One analyst has rated the stock with a hold rating and five have assigned a buy rating to the company’s stock. The company presently has an average rating of “Buy” and a consensus price target of GBX 2,819.17 ($36.84).
GNS traded down GBX 12 ($0.16) during trading on Thursday, reaching GBX 2,586 ($33.79). The company’s stock had a trading volume of 31,115 shares, compared to its average volume of 78,154. The company has a quick ratio of 1.32, a current ratio of 2.08 and a debt-to-equity ratio of 22.58. The firm has a fifty day simple moving average of GBX 2,605.64 and a two-hundred day simple moving average of GBX 2,470.40. Genus has a 1 year low of GBX 2,090 ($27.31) and a 1 year high of GBX 2,950 ($38.55). The company has a market cap of $1.68 billion and a price-to-earnings ratio of -239.44.
Genus plc operates as an animal genetics company in North America, Latin America, rest of Europe, the Middle East, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Research and Development. It sells sows, boars, and semen to breed pigs with various characteristics for pork production under the PIC brand.
Featured Article: Economic Bubble
Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.